Cited by

• Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.

  Kirchheiner J, Meineke I, Müller G, Bauer S, Rohde W, Meisel C, Roots I, Brockmöller J. Kirchheiner J, et al. Clin Pharmacokinet. 2004;43(4):267-78. doi: 10.2165/00003088-200443040-00005. Clin Pharmacokinet. 2004. PMID: 15005635 Clinical Trial.
• Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples.

  Kessler HH, Clarici AM, Stelzl E, Mühlbauer G, Daghofer E, Santner BI, Marth E, Stauber RE. Kessler HH, et al. Clin Diagn Lab Immunol. 2002 Nov;9(6):1385-8. doi: 10.1128/cdli.9.6.1385-1388.2002. Clin Diagn Lab Immunol. 2002. PMID: 12414781 Free PMC article.
• Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0.

  Germer JJ, Lins MM, Jensen ME, Harmsen WS, Ilstrup DM, Mitchell PS, Cockerill FR 3rd, Patel R. Germer JJ, et al. J Clin Microbiol. 2003 Aug;41(8):3503-8. doi: 10.1128/JCM.41.8.3503-3508.2003. J Clin Microbiol. 2003. PMID: 12904346 Free PMC article.
• Dataset for a validated method of non-invasive urine collection using sodium polyacrylate-based diapers for PCR detection of uropathogens.

  Vine T, Carpenter RE, Bridges D. Vine T, et al. Data Brief. 2024 Oct 18;57:111036. doi: 10.1016/j.dib.2024.111036. eCollection 2024 Dec. Data Brief. 2024. PMID: 39534066 Free PMC article.
• Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.

  Ronsin C, Pillet A, Bali C, Denoyel GA. Ronsin C, et al. J Clin Microbiol. 2006 Apr;44(4):1390-9. doi: 10.1128/JCM.44.4.1390-1399.2006. J Clin Microbiol. 2006. PMID: 16597867 Free PMC article.